Orchid Pharma Ltd Share Price & Stock Analysis

Orchid Pharma Ltd (NSE: ORCHPHARMA, BSE: 524372) is a Chennai, Tamil Nadu-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹5,190 Cr, it ranks #824 by market cap among the 6,197 Indian listed companies on FinBizNet, and #24 of 86 in Medicinal Chemicals and Botanical Products. At ₹888.00 (as of 16 Nov 2026), the share price is 22.3% below its 52-week high of ₹1,143.50 and 85.0% above its 52-week low of ₹480.00. The share price is up 5.1% over one year and down 14.5% over three months.

Key Metrics

Current Price₹888.00
Market Cap₹5,190 Cr
NSE SymbolORCHPHARMA
BSE Code524372
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio517.5
Return on Equity0.70%
Return on Assets0.12%
52-Week Range₹480.00 – ₹1,143.50
1-Year Price Change+5.1%
3-Month Price Change-14.5%
Beta (1Y)0.81
HeadquartersChennai, Tamil Nadu
Websitewww.orchidpharma.com

Latest Quarterly Results — Q2 FY27

Revenue₹341 Cr
Net Profit₹29 Cr
Net Margin8.4%
EPS (Basic)₹4.77
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Orchid Pharma Ltd Quarterly Revenue and Profit Trend

Orchid Pharma Ltd reported revenue of ₹341 Cr in Q2 FY27, up 76.3% from ₹194 Cr in Q2 FY26 and up 12.2% from ₹304 Cr in Q1 FY27. It posted a net profit of ₹29 Cr for the quarter, against a net loss of ₹6 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹173 Cr (Q1 FY26) to ₹368 Cr (Q4 FY26). The company reported a net loss in 2 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹341 Cr₹29 Cr8.4%
Q1 FY27₹304 Cr₹3 Cr1.1%
Q4 FY26₹368 Cr₹26 Cr7.0%
Q3 FY26₹207 Cr−₹13 Cr−6.1%
Q2 FY26₹194 Cr−₹6 Cr−3.0%
Q1 FY26₹173 Cr₹15 Cr8.6%
Q4 FY25₹237 Cr₹22 Cr9.4%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 74.45% of Orchid Pharma Ltd's shares as of Sept 2026, against 69.84% in Dec 2025 (+4.61 percentage points). Delivery averaged 47.5% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Orchid Pharma Ltd

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, macrolide, fluoroquinolone, and imidazole. The company also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.

Products and Services

1. Pharmaceuticals-This segment engages in the research, manufacture, and marketing of active pharmaceutical ingredients and finished dosage forms. 2. Bulk-This segment manufactures active pharmaceuticals ingredients. 3. Formulation-This segment manufactures and sells finished dosage forms. 4. Corporate-0

Business Segments

1. Pharmaceuticals-100%

Orchid Pharma Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Orchid Pharma Ltd₹5,190 Cr517.50.70%₹341 Cr+5.1%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Orchid Pharma Ltd?

Orchid Pharma Ltd is trading at ₹888.00, with a market capitalisation of ₹5,190 Cr.

Which sector does Orchid Pharma Ltd belong to?

Orchid Pharma Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Orchid Pharma Ltd?

Orchid Pharma Ltd has a P/E of 517.5 and a return on equity of 0.70%.

What is the stock symbol of Orchid Pharma Ltd?

Orchid Pharma Ltd is listed on the NSE under the symbol ORCHPHARMA and on the BSE under the scrip code 524372.

How has Orchid Pharma Ltd's share price moved over the past year?

Orchid Pharma Ltd's share price is up 5.1% over one year and down 14.5% over three months. Its 52-week range is ₹480.00 to ₹1,143.50.

What were Orchid Pharma Ltd's latest quarterly results?

In Q2 FY27, Orchid Pharma Ltd reported revenue of ₹341 Cr and net profit of ₹29 Cr, with basic EPS of ₹4.77 (consolidated, parsed from the company's exchange filing).

How have Orchid Pharma Ltd's revenue and profit changed over the past year?

Orchid Pharma Ltd reported revenue of ₹341 Cr in Q2 FY27, up 76.3% from ₹194 Cr in Q2 FY26 and up 12.2% from ₹304 Cr in Q1 FY27.

What is the promoter holding in Orchid Pharma Ltd?

Promoters held 74.45% of Orchid Pharma Ltd's shares as of Sept 2026, against 69.84% in Dec 2025 (+4.61 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.